DongKook Pharmaceutical Co. Ltd (086450) - Total Liabilities

Latest as of June 2026: ₩320.04 Billion KRW ≈ $216.89 Million USD

Based on the latest financial reports, DongKook Pharmaceutical Co. Ltd (086450) has total liabilities worth ₩320.04 Billion KRW (≈ $216.89 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 086450 long-term investments to assets to see how much of total assets are deployed in long-term investments.

DongKook Pharmaceutical Co. Ltd - Total Liabilities Trend (2013–2025)

This chart illustrates how DongKook Pharmaceutical Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 086450 total asset value.

DongKook Pharmaceutical Co. Ltd Competitors by Total Liabilities

The table below lists competitors of DongKook Pharmaceutical Co. Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Whanin Pharm KO:016580	Korea	₩57.15 Billion
Triple i Logistics Public Company Limited BK:III	Thailand	฿1.01 Billion
NMP Acquisition Corp. NASDAQ:NMP	USA	$404.20K
Creditwest Faktoring AS IS:CRDFA	Turkey	TL2.27 Billion
BARKBY GRP PLC LS 000860 F:3WY	Germany	€19.49 Million
WTK Holdings Bhd KLSE:4243	Malaysia	RM673.11 Million
Resources Connection Inc F:RCO	Germany	€87.43 Million
Shimmick Corporation Common Stock NASDAQ:SHIM	USA	$275.40 Million

Liability Composition Analysis (2013–2025)

This chart breaks down DongKook Pharmaceutical Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See DongKook Pharmaceutical Co. Ltd balance sheet quality to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.05	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.46	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.29	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how DongKook Pharmaceutical Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for DongKook Pharmaceutical Co. Ltd (2013–2025)

The table below shows the annual total liabilities of DongKook Pharmaceutical Co. Ltd from 2013 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩299.16 Billion ≈ $202.73 Million	+9.11%
2024-12-31	₩274.19 Billion ≈ $185.81 Million	+4.11%
2023-12-31	₩263.36 Billion ≈ $178.48 Million	-1.14%
2022-12-31	₩266.39 Billion ≈ $180.53 Million	-9.85%
2021-12-31	₩295.51 Billion ≈ $200.26 Million	+17.36%
2020-12-31	₩251.80 Billion ≈ $170.64 Million	+38.72%
2019-12-31	₩181.51 Billion ≈ $123.01 Million	+8.54%
2018-12-31	₩167.22 Billion ≈ $113.32 Million	+52.90%
2017-12-31	₩109.37 Billion ≈ $74.12 Million	+24.59%
2016-12-31	₩87.78 Billion ≈ $59.49 Million	+16.76%
2015-12-31	₩75.18 Billion ≈ $50.95 Million	+11.21%
2014-12-31	₩67.60 Billion ≈ $45.81 Million	+20.68%
2013-12-31	₩56.02 Billion ≈ $37.96 Million	--

About DongKook Pharmaceutical Co. Ltd

KQ:086450 Korea Pharmaceuticals

Market Cap

$125.68 Million

₩185.46 Billion KRW

Market Cap Rank

#18424 Global

#825 in Korea

Share Price

₩21100.00

Change (1 day)

+1.20%

52-Week Range

₩16420.00 - ₩29900.00

All Time High

₩31498.93